Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
20
Participants
Timeline
Start Date
November 30, 2004
Study Completion Date
January 31, 2007
Conditions
Non-Small Cell Lung Cancer
Interventions
DRUG
Docetaxel
DRUG
Jin Fu Kang
Trial Locations (1)
10021
Memorial Sloan-Kettering Cancer Center, New York
All Listed Sponsors
lead
Memorial Sloan Kettering Cancer Center
OTHER
NCT00260026 - Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter